Changzhou: the proportion of 81 dosage forms of drugs included in the medical insurance will be reduced to zero
-
Last Update: 2013-08-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Reporters yesterday (26) learned from Changzhou human resources and social security bureau that from September 1, our city will adjust the self payment proportion of some commonly used class B drugs in the medical insurance catalog, involving 81 dosage forms of 54 commonly used famous drugs, including 40 western medicine varieties (47 dosage forms), 14 Chinese patent medicine varieties (34 dosage forms) The proportion of self payment of the 81 dosage forms of drugs has been reduced to zero All the drug expenses will be included in the payment scope of the medical insurance fund and settled directly according to the specified reimbursement proportion The adjustment will benefit 1.14 million insured persons at the same level of the city It is estimated that the medical insurance fund will spend an additional 3 million yuan every year, so as to further reduce the burden of insured persons It is understood that at present, the basic medical insurance in cities and towns of our city implements the 2010 version of Jiangsu price provincial drug catalog, which is regularly adjusted according to the drug storehouse issued by the provincial medical insurance center In addition to Chinese herbal pieces, there are 2772 generic drug varieties (1591 western medicine and 1181 Chinese patent medicine) Among them, there are 585 types of class a drugs, all of which are included in the payment scope of medical insurance fund, and settled according to the specified reimbursement proportion; there are 2187 types of class B drugs, the drug expenses shall be borne by individuals first, and then the rest shall be included in the payment scope of medical insurance fund, and settled according to the specified reimbursement proportion.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.